Latest News and Press Releases
Want to stay updated on the latest news?
-
The University of Texas MD Anderson Cancer Center and HealthEx are developing an AI platform to give patients more control in how their data is used.
-
BOSTON, April 21, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics,...
-
BASEL, Nov. 8, 2024 — ARTIDIS, a clinical-stage health technology company developing the first clinically integrated nanomechanical platform for tissue analytics, today announced a peer-reviewed...
-
CRANBURY, N.J., Oct. 21, 2024 (GLOBE NEWSWIRE) -- The American Journal of Managed Care® (AJMC®), the leading multimedia peer-reviewed journal dedicated to issues in managed care, is pleased to...
-
OAKBROOK TERRACE, Illinois, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Inspiring studies related to two common sources of adverse events in healthcare – handoff communication failures, and bias and...
-
Original research published in Cancer Discovery reveals a RAS(ON) multi-selective inhibitor exhibited robust anti-tumor activity alone or in combination with a RAS(ON) G12C-selective inhibitor in...
-
Cancer Focus Fund is investing $4.5M for clinical trial of Eisbach's novel approach using synthetic lethality to kill PARP inhibitor resistant tumors
-
Replay and MD Anderson announce FDA clearance of IND application for first-in-class T-Cell Receptor Natural Killer (TCR-NK) cell therapy for sarcoma First-in-human Phase 1 study of NY-ESO-1...
-
HOUSTON and BASEL, Switzerland, Oct. 03, 2022 (GLOBE NEWSWIRE) -- ARTIDIS AG, the developer of the first nanomechanical technology platform for tissue analytics, and The University of Texas MD...
-
HOUSTON, Texas, Feb. 19, 2020 (GLOBE NEWSWIRE) -- The University of Texas MD Anderson Cancer Center today announced the Houston Dash will join the institution's efforts toward one goal: end cancer....